These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23236709)

  • 21. Analyzing generic and branded substitution patterns in the Netherlands using prescription data.
    Pechlivanoglou P; van der Veen WJ; Bos JH; Postma MJ
    BMC Health Serv Res; 2011 Apr; 11():89. PubMed ID: 21524312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017.
    Rome BN; Lee CC; Gagne JJ; Kesselheim AS
    Value Health; 2021 Jun; 24(6):804-811. PubMed ID: 34119078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of drug samples on prescribing to the uninsured.
    Miller DP; Mansfield RJ; Woods JB; Wofford JL; Moran WP
    South Med J; 2008 Sep; 101(9):888-93. PubMed ID: 18708971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regress for expensive medicines? When costly therapies are not a problem].
    Nitz G
    MMW Fortschr Med; 2013 Feb; 155(3):12. PubMed ID: 23573755
    [No Abstract]   [Full Text] [Related]  

  • 25. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generic substitution, financial interests, and imperfect agency.
    Rischatsch M; Trottmann M; Zweifel P
    Int J Health Care Finance Econ; 2013 Jun; 13(2):115-38. PubMed ID: 23494466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of changes in national prescribing conditions for statins on their public expenditure and utilization in the Czech Republic 1997-2013.
    Fuksa L; Vocelka M; Vytrisalova M
    Health Policy; 2015 Sep; 119(9):1255-64. PubMed ID: 25929214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Private expenditures on brand name prescription drugs after generic entry.
    Balaban DY; Dhalla IA; Law MR; Bell CM
    Appl Health Econ Health Policy; 2013 Oct; 11(5):523-9. PubMed ID: 23979876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cost reduction with project based prescription of generic ACE inhibitors].
    Wolzt M; Ohrenberger G; Reichardt B
    Wien Klin Wochenschr; 2003 Jan; 115(1-2):23-8. PubMed ID: 12658907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electronic notifications about drug substitutes can change physician prescription habits: a cross-sectional observational study.
    Zuker A; Heart T; Parmet Y; Pliskin N; Pliskin JS
    Med Decis Making; 2011; 31(3):395-404. PubMed ID: 21127317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Greek students' attitudes, perception and knowledge regarding generic medicines in times of economic crisis: a cross-sectional study.
    Domeyer PJ; Katsari V; Sarafis P; Aletras V; Niakas D
    BMC Med Educ; 2018 Nov; 18(1):262. PubMed ID: 30442145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The patients' cost of the montelukast therapy due to the generic substitution].
    Répásy B; Endrei D; Zemplényi A; Ágoston I; Boncz I
    Orv Hetil; 2018 Apr; 159(17):682-687. PubMed ID: 29681174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unintended effects of a cost-containment policy: results of a natural experiment in Germany.
    Schöffski O; Graf von der Schulenburg JM
    Soc Sci Med; 1997 Nov; 45(10):1537-9. PubMed ID: 9351143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of drug plans on adherence to and the cost of antihypertensive medications among patients covered by a universal drug insurance program.
    Després F; Perreault S; Lalonde L; Forget A; Kettani FZ; Blais L
    Can J Cardiol; 2014 May; 30(5):560-7. PubMed ID: 24613090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Measures to reduce costs for prescriptions in Vienna--preliminary analysis].
    Tönies H
    Wien Med Wochenschr; 2009; 159(7-8):196-201. PubMed ID: 19412694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to in-office dispensing of generic antibiotic samples.
    Kogut SJ; Spooner LM
    J Manag Care Pharm; 2009; 15(1):62-5. PubMed ID: 19125551
    [No Abstract]   [Full Text] [Related]  

  • 39. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

  • 40. A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China.
    Zeng W
    BMC Health Serv Res; 2013 Oct; 13():390. PubMed ID: 24093493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.